Universal prophylaxis with valganciclovir versus preemptive therapy in minimizing the risk of cytomegalovirus infection and disease in high-risk and intermediate-risk kidney transplant recipients: a single-center experience
2019 ◽
Vol 19
(3)
◽
pp. 68
2010 ◽
Vol 42
(8)
◽
pp. 2947-2949
◽
2013 ◽
Vol 45
(1)
◽
pp. 182-184
◽
2017 ◽
Vol 49
(8)
◽
pp. 1766-1772
◽
2018 ◽
Vol 50
(10)
◽
pp. 3452-3459
◽
2018 ◽
Vol 50
(10)
◽
pp. 3351-3355
◽